Vascular Stent Market

The report "Vascular Stent Market by Technology (Dug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029", is valued at an estimated 11.4 billion in 2024 and is projected to reach USD 15.6 billion by 2029, at a CAGR of 6.5% during the forecast period.

Browse 620 market data Tables and 53 Figures spread through 426 Pages and in-depth TOC on "Vascular Stent Market by Technology (Dug-eluting, Covered), Product (Coronary, Peripheral (Carotid, Renal)), MOD (Balloon-expandable, Self-expanding), Material (Metal (PtCr,CoCr), Polymer), End User (Hospitals, Cardiac Center) - Global Forecast to 2029"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/vascular-stent-market-199869009.html

The growth in the vascular stent market is driven by rising incidences of vascular diseases such as coronary artery disease, peripheral artery disease, endovascular aortic aneurysm, the technological advancement in stents, and Increasing patient preference for minimally invasive surgeries due to shorter hospital stays. The development of bioresorbable vascular scaffold stents poses a lucrative opportunity in the Vascular stent market. But availability of alternative treatment method such as open surgical treatments for vascular disease is restraining the vascular stent market during the forecast period. Additionally, the decreasing cost of stents and complications associated with stenting procedures are hindering market growth.

By Mode of delivery, Balloon-expandable Stents is the growing segment in the vascular stent market in 2023.

Based on mode of delivery, the vascular stent market is segmented into ballon-expandable stent and self-expanding stents. Among these, in 2023, the balloon expandable stent is the fastest growing segment in the vascular stent market, this is due to increasing prevalence of coronary heart diseases. Reduced recoil when compared to self-expanding stents is one of the main benefits of balloon-expandable stents, particularly in calcified lesions. They are favored for renal and coronary stenting because of this property. Balloon-expandable stents successfully preserve the vessel's patency and prevent elastic recoil due to their accurate placement and high radial force. Furthermore, the possibility of overexpansion and vessel damage is reduced by their regulated expansion. balloon-expandable stents are among the dependable and efficient treatment alternatives that are in greater demand as coronary heart disease rates climb. The balloon-expandable segment of the vascular stents market is growing at a quick pace due to the growing requirement for precise and stable stent implantation in the treatment of heart disorders.

By Material, Cobalt Chromium is the fastest growing in the Vascular stent market in 2023.

Based on material, the vascular stent market is segmented into metallic material, and polymer material. The metal segment is again divided into Cobalt Chromium, Platinum Chromium, Nickel Titanium, and Stainless Steel. Among these, in 2023, cobalt chromium (CoCr) segment is the fastest growing in the vascular stents market. This is because it has greater attributes than stainless steel. CoCr stents provide superior radiopacity and radial strength, allowing for the use of thinner struts without sacrificing radiological visibility. Cobalt chromium is used to make the majority of balloon-expandable stents because to its superior mechanical, radiopaque, and biocompatibility qualities. CoCr stents' thin-strut shape lowers the risk of thrombosis and restenosis following stent insertion. CoCr stents undergo less elastic recoil and preserve X-ray visibility both during and after percutaneous coronary intervention, while having smaller struts than stainless steel stents. Because of this, they are very effective at maintaining blood vessel openings and facilitating appropriate blood flow. Thus, the CoCr sector is the fastest growing in this market due to its combination of mechanical strength, visibility, and biocompatibility.

Hospitals segment accounts for the largest share by end users of the vascular stent market in 2023.

Based on end users, the vascular stent market is segmented into hospitals, and cardiac centers, among these, in 2023, hospital segment is the fastest growing in the vascular stents market. The rising number of hospital admissions for cardiovascular illnesses is the cause of this. There is an increase in hospital visits and treatments due to the growing number of instances of cardiovascular disease worldwide. For instance, the US had 6.4% of emergency department visits in 2021 with medical records indicating coronary artery disease, ischemic heart disease, or a history of myocardial infarction. This information comes from the Centers for Disease Control and Prevention. Vascular stents are in high demand in hospitals due to the rise in cardiovascular problems since these devices are essential for treating these illnesses. Since hospitals are the main locations for completing stent-related procedures, this has contributed to the devices' rapid market growth.

North America dominates the global vascular stent market in 2023.

The vascular stent market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The North American region accounts for the largest share in the vascular stent market in 2023, due to rising prevalence of cardiac diseases. In 2022, heart disease claimed the lives of 702,880 Americans, or 1 in every 5 fatalities, according to the Centers for Disease Control and Prevention. The need for efficient therapies, such vascular stents, is greatly fueled by the rising prevalence of cardiovascular diseases. In North America, the market for vascular stents is expanding in tandem with the increasing demand to treat these illnesses. The region's advanced healthcare system and high degree of cardiovascular health awareness contribute to its leading position in the vascular stents market.

Key Players

Prominent players in the Vascular stent market include, Medtronic Plc (Ireland), Abbott Laboratories (US), Boston Scientific Corporation (US), B Braun SE (Germany), Terumo Corporation (Japan), Biotronik SE & Co.KG (Germany), Shanghai Microport Medical (Group) Co., Ltd (China), Meril Life Science Pvt. Ltd (India), Sahajanan Medical Technologies Limited (India), Becton, Dickinson, and Company (US), W.L. Gore & Associates, Inc (US), Cordis Corporation (US), Artivion Inc (US), Stryker Corporation (US), LifeTech Scientific Corporation (China), Translumina (Germany), Lepu Medical Technology (Beijing) Co., Ltd (China), Elixir Medical (US) , Endologix LLC. (US), Biosensors International Group, Ltd (Singapore), Cook Medical (Indiana), Insitu Technologies Inc (US), iVascular (Spain), OrbusNeich Medical Group Holdings Limited (China), Alvimedica (Turkey).

Don’t miss out on business opportunities in Vascular Stent Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]